drugset / Trial / NCT07124871

PRP Exosomes Therapy for Erectile Dysfunction

NCT07124871 ↗

NaSingle-groupOpen-labelTreatment

Summary

It will be a Single-arm, single-center, feasibility clinical trial with Primary Objective to investigate the treatment efficacy of PRP-derived exosomes injection in men with mild-moderate vasculogenic ED, as measured by the International Index of Erectile Function (IIEF). Also secondary objectives will be to study the adverse events and safety of the PRP-derived exosomes injection treatment in vasculogenic ED patients Study Centers The study will be carried out at Saint Lucas Hospital, Thessaloniki, Greece. Laboratory tests of all patients will be performed at the hospital's microbiology laboratory. PRP-derived exosomes preparation and application will take place at the Regenerative Clinic.

Timeline

Start
2025-06-20
Primary completion
2026-02
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP-derived exosomes injection Unknown 9 ml Other